TNFRSF17 and Miyoshi myopathy: GSI-pretreated MM target cells again significantly augmented BCMA-specific MM cell lysis induced by patient T cells (P < 0.05), regardless which BCMAxCD3 BisAb or target MM cells were used (Fig. 2D and Supplementary Fig. S2E).